Blood products giant CSL has appointed Paul McKenzie as chief executive, who will take over following CEO Paul Perreault’s decade of leadership. The former chief operating officer will take on the new role in March, and Mr Perreault will remain with the company until his retirement in September. After spending 25 years at the biotech business […]

This post was originally published on Michael West.